Loading...
  • chemotherapy
  • Apart from the strong prevalence of cancer and consequently increasing demand for radiation-based chemotherapy, the radiodermatitis market is being fueled by increased number of industry-institute and industry-academia partnerships. (sbwire.com)
  • Increase in factors influencing co-morbid conditions and adverse events during radiation with chemotherapy, innovation in product offering, and partnerships and agreements pertaining to manufacturing and distribution of radiodermatitis products are some of the other drivers of this market. (sbwire.com)
  • Healthcare
  • Some of the key players of the radiodermatitis market, such as 3M Healthcare, Acelity, Molnlycke Health Care, Smith & Nephew PLC, and Convatec, Inc., are prominent names in the field of medical devices and drug manufacturing, and are constantly pursuing the development of innovative products as well as expanding geographically to find unmet demands. (sbwire.com)
  • treatment
  • Radiodermatitis can be a dose-limiting side effect resulting in cancer treatment delays or even cancer treatment cessation, as well as significant pain and limitation of usual lifestyle activities. (ons.org)
  • The demand for radiodermatitis treatment is also accentuated by unmet medical needs of consumers in emerging as well as developed regions. (southdakotachronicle.com)
  • In addition, they have signed a joint agreement to enhance their R&D capabilities and commercialize new patented technological platforms.Other factors such as escalating number of product launches with respect to radiodermatitis treatment and increasing demand for these products are expected to boost the overall market growth. (southdakotachronicle.com)
  • drug
  • The pipeline guide evaluates Radiodermatitis (Toxicology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. (aarkstore.com)
  • growth
  • Online store is set to witness rapid growth due to the various benefits rendered to a radiodermatitis affected patient unwilling to visit outdoor medical stores. (medindia.net)